news pharmeasy valuation: Pharmeasy eyes IPO at $3 billion valuation, buys rival Medlife May 26, 2021
news Vaccitech IPO: Oxford Covid-19 vaccine tech maker Vaccitech targets $613 mn valuation in US IPO April 26, 2021